GB701831A - Process for the production of suppositories containing medicaments - Google Patents
Process for the production of suppositories containing medicamentsInfo
- Publication number
- GB701831A GB701831A GB24148/51A GB2414851A GB701831A GB 701831 A GB701831 A GB 701831A GB 24148/51 A GB24148/51 A GB 24148/51A GB 2414851 A GB2414851 A GB 2414851A GB 701831 A GB701831 A GB 701831A
- Authority
- GB
- United Kingdom
- Prior art keywords
- calcium
- salts
- cocoa butter
- sodium
- cobalt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Suppositories containing 20-50 per cent by weight of a crystalline medicament other than water-soluble calcium salts of water-soluble fatty acids containing not more than 6 carbon atoms in the molecule or calcium lactate or calcium sodium lactate, are prepared by grinding the medicament in a vibrating mill to a particle size of 1-10 microns, and then incorporating the powder in the molten suppository base at 40-60 DEG C. If necessary, the crystalline solids are dried or dehydrated before grinding. Specific examples of substances which are first so treated are: Cobalt salts such as cobalt chloride and cobalt sulphate, sodium nicotinate, salts of theophylline, codeine phosphate, codeine hydrochloride, salts of barbituric acid, calcium acetate-calcium chloride double salt, and ferrous sulphate. Other finely divided medicaments may be incorporated in the suppositories for the purpose of rendering a medicament more soluble in the base or therapeutically more effective. Specified combinations are (a) ferrous sulphate, ascorbic acid and cocoa butter, with or without the further addition of cobalt sulphate; (b) theobromine sodium salicylate, theophylline, papaverine, sodium phenyl ethyl barbiturate, calcium acetate and cocoa butter; (c) 4-dimethylamino-1-phenyl-2, 3-dimethyl pyrazolone, 1-phenyl-2, 3-dimethyl pyrazolone, codeine phosphate (or codeine hydrochloride), calcium acetate and suppository base; (d) magnesium acetate, magnesium propionate and cocoa butter; and (e) calcium acetate, nicotinic acid amide and ascorbic acid and cocoa butter. Other specified substances are sodium salicylate, pacetyl phenetidine, bromoisovaleryl carbamide, bromodiethylacetyl carbamide, hydantoins, quinine hydrochloride and the sulphonamides. Specifications 683,192 and 689,722 are referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE701831X | 1950-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB701831A true GB701831A (en) | 1954-01-06 |
Family
ID=6611694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB24148/51A Expired GB701831A (en) | 1950-10-19 | 1951-10-16 | Process for the production of suppositories containing medicaments |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR1043977A (en) |
GB (1) | GB701831A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1008850B (en) * | 1954-10-14 | 1957-05-23 | Huels Chemische Werke Ag | Lubrication of internal combustion engines |
US10905699B2 (en) * | 2015-07-08 | 2021-02-02 | Dr. Falk Pharma Gmbh | Pharmaceutical formulation for the treatment of inflammatory changes to the rectum |
-
1951
- 1951-10-16 GB GB24148/51A patent/GB701831A/en not_active Expired
- 1951-10-18 FR FR1043977D patent/FR1043977A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1008850B (en) * | 1954-10-14 | 1957-05-23 | Huels Chemische Werke Ag | Lubrication of internal combustion engines |
US10905699B2 (en) * | 2015-07-08 | 2021-02-02 | Dr. Falk Pharma Gmbh | Pharmaceutical formulation for the treatment of inflammatory changes to the rectum |
US11738032B2 (en) | 2015-07-08 | 2023-08-29 | Dr. Falk Pharma Gmbh | Pharmaceutical formulation for the treatment of inflammatory changes to the rectum |
Also Published As
Publication number | Publication date |
---|---|
FR1043977A (en) | 1953-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
EG10530A (en) | Process for preparation of 7-aminocephalosporanic acid derivatives having a substituent at position 7,their use as antibiotics | |
GB1333471A (en) | Imidazoline derivatives and process for preparing the same | |
GB701831A (en) | Process for the production of suppositories containing medicaments | |
GB944331A (en) | Assimilable iron preparations | |
GB777525A (en) | Improved grain products and the manufacture thereof | |
IE37655B1 (en) | Derivatives of 1-phenoxy-3-amino-propane-2-ol and process for their production | |
ES351689A1 (en) | Improvements in or relating to Compositions Containing Choline Chloride | |
GB950521A (en) | Pyrimidinyl-guanazoles | |
IE42191L (en) | 7ó-methoxy cephalosporin compounds. | |
US2704287A (en) | 5-(2-cyclohexylethyl)-2-thiohydantoin and process | |
GB1015800A (en) | Improvements in or relating to nicotinic acid derivatives | |
GB1134682A (en) | Improvements in or relating to derivatives of 6-aminopenicillanic acid | |
US3322749A (en) | Derivatives of penicillanic acid and cephalosporanic acid | |
GB1348259A (en) | Process for the preparation of 10-oxo-7,10-dihydro-1h-dioxino- 5,4-f-quinolyl-9-carboxylic acids | |
GB1028563A (en) | Antibacterial derivative of 7-aminocephalosporanic acid | |
FR1054999A (en) | Process for the preparation of hexamethylenediamine and salts in purified form and resulting products | |
GB1313443A (en) | Triiodo-phenylalkyl ethers their application in x-ray contrast agents and process for their production | |
US2098448A (en) | Complex compounds of cinchophen and its derivatives | |
GB1159748A (en) | Thiol-Type Thiamine Thionocarbonates | |
GB1255034A (en) | Penicillin esters | |
GB928574A (en) | Derivatives of thiadiazole dicarboxylic acid | |
GB968502A (en) | O,s-disubstituted thiol-type thiamines and process for preparing them | |
GB807115A (en) | New nicotinic acid esters and process of making the same | |
AU1662753A (en) | Process forthe preparation of 2-amino-4-dimethylamino-5-(4 chlorophenyl)-6-ethyl pyrimidine and acid addition salts |